• Online Features  This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (361)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Psychiatry  • Bipolar Disorder  • Depression  • Alert me on articles by topic  Social Bookmarking   What's this?

Kathleen R. Merikangas, PhD; Hagop S. Akiskal, MD; Jules Angst, MD; Paul E. Greenberg, MA; Robert M. A. Hirschfeld, MD; Maria Petukhova, PhD; Ronald C. Kessler, PhD

Arch Gen Psychiatry. 2007;64(5):543-552.

Context  There is growing recognition that bipolar disorder (BPD) has a spectrum of expression that is substantially more common than the 1% BP-I prevalence traditionally found in population surveys.

Objective  To estimate the prevalence, correlates, and treatment patterns of bipolar spectrum disorder in the US population.

Design  Direct interviews.

Setting  Households in the continental United States.

Participants  A nationally representative sample of 9282 English-speaking adults (aged 18 years).

Main Outcome Measures  Version 3.0 of the World Health Organization's Composite International Diagnostic Interview, a fully structured lay-administered diagnostic interview, was used to assess DSM-IV lifetime and 12-month Axis I disorders. Subthreshold BPD was defined as recurrent hypomania without a major depressive episode or with fewer symptoms than required for threshold hypomania. Indicators of clinical severity included age at onset, chronicity, symptom severity, role impairment, comorbidity, and treatment.

Results  Lifetime (and 12-month) prevalence estimates are 1.0% (0.6%) for BP-I, 1.1% (0.8%) for BP-II, and 2.4% (1.4%) for subthreshold BPD. Most respondents with threshold and subthreshold BPD had lifetime comorbidity with other Axis I disorders, particularly anxiety disorders. Clinical severity and role impairment are greater for threshold than for subthreshold BPD and for BP-II than for BP-I episodes of major depression, but subthreshold cases still have moderate to severe clinical severity and role impairment. Although most people with BPD receive lifetime professional treatment for emotional problems, use of antimanic medication is uncommon, especially in general medical settings.

Conclusions  This study presents the first prevalence estimates of the BPD spectrum in a probability sample of the United States. Subthreshold BPD is common, clinically significant, and underdetected in treatment settings. Inappropriate treatment of BPD is a serious problem in the US population. Explicit criteria are needed to define subthreshold BPD for future clinical and research purposes.

Author Affiliations: Intramural Research Program, Section on Developmental Genetic Epidemiology, National Institute of Mental Health, Bethesda, Md (Dr Merikangas); the International Mood Center, University of California San Diego and VA Psychiatry Service, San Diego (Dr Akiskal); Zurich University Psychiatric Hospital, Zurich, Switzerland (Dr Angst); Analysis Group, Boston, Mass (Mr Greenberg); Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston (Dr Hirschfeld); and Department of Health Care Policy, Harvard Medical School, Boston (Drs Petukhova and Kessler).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Socioeconomic disadvantage affects course and recurrence of psychiatric disability
Stansfeld
Occup. Environ. Med. 2011;68:789-790.
FULL TEXT  

Bipolar depression: clinically missed, pharmacologically mismanaged
Lloyd et al.
Therapeutic Advances in Psychopharmacology 2011;1:153-162.
ABSTRACT  

A High-Risk Study of Bipolar Disorder: Childhood Clinical Phenotypes as Precursors of Major Mood Disorders
Nurnberger et al.
Arch Gen Psychiatry 2011;68:1012-1020.
ABSTRACT | FULL TEXT  

Structural Neuroimaging Studies in Major Depressive Disorder: Meta-analysis and Comparison With Bipolar Disorder
Kempton et al.
Arch Gen Psychiatry 2011;68:675-690.
ABSTRACT | FULL TEXT  

Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania
Young et al.
J Psychopharmacol 2011;25:934-943.
ABSTRACT | FULL TEXT  

Detection of bipolar disorder
Young and MacPherson
Br. J. Psychiatry 2011;199:3-4.
ABSTRACT | FULL TEXT  

Unrecognised bipolar disorder in primary care patients with depression
Smith et al.
Br. J. Psychiatry 2011;199:49-56.
ABSTRACT | FULL TEXT  

Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease
O'Sullivan et al.
J. Neurol. Neurosurg. Psychiatry 2011;82:620-622.
ABSTRACT | FULL TEXT  

Predictors of lithium response in bipolar disorder
Tighe et al.
Therapeutic Advances in Chronic Disease 2011;2:209-226.
ABSTRACT  

Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas et al.
Arch Gen Psychiatry 2011;68:241-251.
ABSTRACT | FULL TEXT  

Bipolar Disorder and Violent Crime: New Evidence From Population-Based Longitudinal Studies and Systematic Review
Fazel et al.
Arch Gen Psychiatry 2010;67:931-938.
ABSTRACT | FULL TEXT  

The course of bipolar disorder
Saunders and Goodwin
Adv. Psychiatr. Treat. 2010;16:318-328.
ABSTRACT | FULL TEXT  

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Diazgranados et al.
Arch Gen Psychiatry 2010;67:793-802.
ABSTRACT | FULL TEXT  

Nuclear Receptor Rev-Erb-{alpha} Circadian Gene Variants and Lithium Carbonate Prophylaxis in Bipolar Affective Disorder
Campos-de-Sousa et al.
J Biol Rhythms 2010;25:132-137.
ABSTRACT  

Longitudinal Course of Bipolar I Disorder: Duration of Mood Episodes
Solomon et al.
Arch Gen Psychiatry 2010;67:339-347.
ABSTRACT | FULL TEXT  

Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study
Tijssen et al.
Br. J. Psychiatry 2010;196:102-108.
ABSTRACT | FULL TEXT  

Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
Squassina et al.
Hum Genomics Proteomics 2010;2:159761-159761.
ABSTRACT | FULL TEXT  

Heterogeneity of DSM-IV Major Depressive Disorder as a Consequence of Subthreshold Bipolarity
Zimmermann et al.
Arch Gen Psychiatry 2009;66:1341-1352.
ABSTRACT | FULL TEXT  

Safety and Efficacy of Quetiapine in Bipolar Depression
Bogart and Chavez
The Annals of Pharmacotherapy 2009;43:1848-1856.
ABSTRACT | FULL TEXT  

Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Caley
The Annals of Pharmacotherapy 2009;43:1890-1892.
ABSTRACT | FULL TEXT  

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology
Goodwin and Consensus Group of the British Association for Psy
J Psychopharmacol 2009;23:346-388.
ABSTRACT  

Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry
Scott et al.
Proc. Natl. Acad. Sci. USA 2009;106:7501-7506.
ABSTRACT | FULL TEXT  

Lifetime Psychiatric Disorders in School-aged Offspring of Parents With Bipolar Disorder: The Pittsburgh Bipolar Offspring Study
Birmaher et al.
Arch Gen Psychiatry 2009;66:287-296.
ABSTRACT | FULL TEXT  

Quality of Life in Pediatric Bipolar Disorder
Freeman et al.
Pediatrics 2009;123:e446-e452.
ABSTRACT | FULL TEXT  

Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge
Hassan and Lage
Am J Health Syst Pharm 2009;66:358-365.
ABSTRACT | FULL TEXT  

The Burden of Mental Disorders
Eaton et al.
Epidemiol Rev 2008;30:1-14.
ABSTRACT | FULL TEXT  

Child Bipolar I Disorder: Prospective Continuity With Adult Bipolar I Disorder; Characteristics of Second and Third Episodes; Predictors of 8-Year Outcome
Geller et al.
Arch Gen Psychiatry 2008;65:1125-1133.
ABSTRACT | FULL TEXT  

Family-Focused Treatment for Adolescents With Bipolar Disorder: Results of a 2-Year Randomized Trial
Miklowitz et al.
Arch Gen Psychiatry 2008;65:1053-1061.
ABSTRACT | FULL TEXT  

The broad clinical spectrum of bipolar disorder: implications for research and practice
Smith et al.
J Psychopharmacol 2008;22:397-400.
 

Clinical questions and uncertainty -- prolactin measurement in patients with schizophrenia and bipolar disorder
Walters and Jones
J Psychopharmacol 2008;22:82-89.
ABSTRACT  

Bipolar Disorder and Weight Gain: A Multifactorial Assessment
Simmons-Alling and Talley
J Am Psychiatr Nurses Assoc 2008;13:345-352.
ABSTRACT  

Specificity of Bipolar Spectrum Conditions in the Comorbidity of Mood and Substance Use Disorders: Results From the Zurich Cohort Study
Merikangas et al.
Arch Gen Psychiatry 2008;65:47-52.
ABSTRACT | FULL TEXT  

The Role of the Family in the Course and Treatment of Bipolar Disorder
Miklowitz
Current Directions in Psychological Science 2007;16:192-196.
ABSTRACT | FULL TEXT